A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies
Thomas Jefferson University
Thomas Jefferson University
University of Chicago
University of Washington
Massachusetts General Hospital
University of Ulm
BeOne Medicines
Eli Lilly and Company